title: Prostate-specific antigen screening in prostate cancer: perspectives on the evidence.
authors.affiliation: Affiliations of authors: Minneapolis VA Center for Chronic Disease Outcomes Research and the University of Minnesota School of Medicine, Minneapolis, MN (TJW); Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY (PTS, SVC); Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC (EB).
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Wilt
authors.forename: Peter T
authors.initials: PT
authors.lastname: Scardino
authors.forename: Sigrid V
authors.initials: SV
authors.lastname: Carlsson
authors.forename: Ethan
authors.initials: E
authors.lastname: Basch
mesh_terms: D000367:Age Factors; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D002755:Choice Behavior; D003657:Decision Making; D055088:Early Detection of Cancer / Q000009:adverse effects* / Q000379:methods; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000009:adverse effects* / Q000379:methods; D008875:Middle Aged; D011159:Population Surveillance; D017410:Practice Guidelines as Topic; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen